The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
"I said, I don't care."The symptom making it difficult for him to communicate is called aphasia.It's common among people, like Walsh, who have Alzheimer's disease.For his wife, Karen, it was the first ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...